首页|改良ARMS对难治性胃食管反流病的治疗效果及对炎症指标和术后并发症的影响

改良ARMS对难治性胃食管反流病的治疗效果及对炎症指标和术后并发症的影响

Therapeutic effect of improved ARMS on treatment of refractory gastroesophageal reflux disease and its influence on inflammatory indicators and postoperative complications

扫码查看
目的 探究改良内镜下抗反流黏膜切除术(ARMS)对难治性胃食管反流病(RGERD)的治疗效果及对炎症指标和术后并发症的影响.方法 选择2021 年 1 月至 2022 年 6 月舟山医院收治的 60 例RGERD患者作为研究对象.采用随机数表法将患者分为试验组和对照组,每组各 30例.试验组行改良ARMS治疗,对照组行ARMS治疗.记录 2 组的手术相关指标,根据治疗后患者的临床症状及胃十二指肠镜检查结果评估临床疗效.应用咽喉反流症状指数量表(RSI)和安德森吞咽困难量表(MDADI)评估患者的咽喉反流和吞咽情况.比较 2 组的C反应蛋白(CRP)、IL-6 和白细胞计数(WBC)水平.分别于术前和术后 6 个月行胃镜检查,对患者的胃食管阀瓣进行Hill分级.应用胃食管反流病健康相关生存质量量表(GERD-HRQL)评估患者的生存质量.采用门诊和电话的方式于患者术后进行随访,比较 2 组的术后并发症情况.结果 试验组的治疗总有效率为 93.33%,高于对照组(83.33%),但差异无统计学意义(P>0.05).与对照组相比,试验组的手术时间较长,术后 1 个月和 6 个月的RSI指数均较低,而MDADI评分均较高,术后 1 周和 2 周的血清CRP、IL-6 和WBC水平均较低,差异均有统计学意义(P均<0.05).与术前相比,2 组术后 6 个月的胃食管阀瓣Hill分级均降低,差异均有统计学意义(P均<0.05).试验组术后6个月的胃食管阀瓣Hill分级Ⅰ级占比为 46.67%,高于对照组(30.00%),但差异无统计学意义(P>0.05).与对照组相比,试验组术后 1 个月和 6 个月的GERD-HRQL评分均较低,差异均有统计学意义(P均<0.05).2 组患者均顺利完成手术治疗,无死亡病例,仅对照组出现 2 例吞咽困难,该组术后并发症的发生率为 6.67%.结论 改良ARMS治疗RGERD的疗效确切,可有效缓解术后炎症性应激反应,减少咽喉反流,降低术后吞咽困难的发生率,进而提高患者的生存质量,具有临床推广价值.
Objective This paper attempts to explore the therapeutic effect of improved endoscopic anti reflux mucosal resection(ARMS)on refractory gastroesophageal reflux disease(RGERD)and its impact on inflammatory indicators and postoperative complications.Methods A total of 60 patients with RGERD admitted to Zhoushan Hospital from January 2021 to June 2022 were selected as the study subjects who were divided into an experimental group and a control group using a random number table method,with 30 cases in each group.The experimental group received improved ARMS treatment,while the control group received ARMS treatment.The surgical related indicators of the two groups were recorded,and the clinical efficacy and the results of gastroduodenoscopy were evaluated based on the clinical symptoms of patients after treatment.The throat reflux symptom index(RSI)and Anderson dysphagia inventory(MDADI)were used to evaluate the pharyngeal reflux and swallowing condition.The levels of C-reactive protein(CRP),IL-6,and white blood cell count(WBC)were compared between the two groups.Gastroscopy was performed before and 6 months after surgery,and the gastroesophageal valve was graded by Hill.The quality of life of the subjects was evaluated using the gastroesophageal reflux disease health related quality of life scale(GERD-HRQL).Follow-up of the subjects after surgery was conducted using outpatient and telephone methods,and the postoperative complications were compared between the two groups.Results The total effective rate of treatment in the experimental group is 93.33%,higher than that in the control group(83.33%),but the difference is not statistically significant(P>0.05).Compared with the control group,the experimental group has a longer operation time,a lower RSI index at 1 month and 6 months after surgery,a higher MDADI score,and lower serum CRP,IL-6 and WBC levels at 1 week and 2 weeks after surgery,with statistically significant differences(P<0.05).Compared with the preoperative results,the Hill grading of gastroesophageal valve flap in the two groups decrease at 6 months after surgery,with statistically significant differences(P<0.05).The proportion of Hill grade Ⅰ in the experimental group is 46.67%,which is higher than that in the control group(30.00%),but the difference is not statistically significant(P>0.05).Compared with the control group,the GERD-HRQL scores of the experimental group at 1 month and 6 months after surgery are lower,with statistically significant differences(P<0.05).All the subjects in the two groups successfully completed the surgical treatment,with no death cases,only 2 cases of dysphagia in the control group,and a 6.67%incidence of postoperative complications.Conclusions The effect of improved ARMS on the treatment of RGERD is accurately definite,which can effectively alleviate postoperative inflammatory stress response,reduce pharyngeal reflux and incidence of postoperative dysphagia,and thus improve the quality of life of patients.It has clinical promotion value.

Refractory gastroesophageal reflux diseaseImproved endoscopic anti-reflux mucosal resectionInflammatory factorComplications

徐汤舟、邱冰峰、毛吉波、徐骐

展开 >

316000 浙江省舟山医院消化内科

难治性胃食管反流病 改良内镜下抗反流黏膜切除术 炎症因子 并发症

舟山市科技计划项目

2021C31093

2024

国际消化病杂志
上海市医学科学技术情报研究所

国际消化病杂志

CSTPCD
影响因子:0.796
ISSN:1673-534X
年,卷(期):2024.44(1)
  • 21